Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
41.49
-0.47 (-1.12%)
At close: Oct 23, 2026, 4:00 PM EDT
41.94
+0.45 (1.08%)
After-hours: Oct 23, 2026, 5:23 PM EDT
Scholar Rock Holding Employees
Scholar Rock Holding had 289 employees as of December 31, 2025. The number of employees increased by 93 or 47.45% compared to the previous year. That makes Scholar Rock Holding the 24,190th largest employer in the world and 3,106th in the United States.
Employees
289
Change (1Y)
93
Growth (1Y)
47.45%
Revenue / Employee
n/a
Profits / Employee
-$1,413,810
Market Cap
5.05B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 289 | 93 | 47.45% |
| Dec 31, 2024 | 196 | 46 | 30.67% |
| Dec 31, 2023 | 150 | 36 | 31.58% |
| Dec 31, 2022 | 114 | -31 | -21.38% |
| Dec 31, 2021 | 145 | 26 | 21.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| CRISPR Therapeutics AG | 393 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Kodiak Sciences | 141 |
| Definium Therapeutics | 106 |
SRRK News
- 3 days ago - Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026 - Business Wire
- 7 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 15 days ago - Scholar Rock resubmits MAA for apitegromab to the EMA - TheFly
- 15 days ago - Scholar Rock Resubmits Apitegromab Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA) - Business Wire
- 4 weeks ago - Scholar Rock added to Best Ideas List at Wedbush - TheFly
- 4 weeks ago - Scholar Rock price target raised to $77 from $76 at Truist - TheFly
- 4 weeks ago - Scholar Rock price target raised to $70 from $63 at JPMorgan - TheFly
- 5 weeks ago - Scholar Rock says FDA requested pregnancy safety study for Isembyld - TheFly